Track the ProSomnus, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 16 February 2024 (Attribution). Among the most active insiders: Dow Brian B. Every trade is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ProSomnus, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental score
Ranked 24,724 of 29,064 companies
26.7
score / 100
Value
23
Quality
31
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn37%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ProSomnus, Inc. es una empresa enfocada en el desarrollo de soluciones para trastornos del sueño. Se especializa en el diseño de dispositivos médicos para mejorar la calidad del sueño de los pacientes.